Skip to content

Observational prospective single center study for the usefulness of AminoIndex cancer risk screening (AICS) in early gastric cancer

Observational prospective single center study for the usefulness of AminoIndex cancer risk screening (AICS) in early gastric cancer - Prospective study for the usefulness of AminoIndex cancer risk screening (AICS) in early gastric cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000033733
Enrollment
90
Registered
2018-08-13
Start date
2018-10-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Early gastric cancer

Interventions

None listed

Sponsors

Yokohama City University Center for Novel and Exploratory Clinical Trials
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) 20 to 90 years old male and female who can examine AICS and endoscopic examination. (2) Patients with early gastric cancer or suspicious of early gastric cancer that endoscopically resectable. (3) Patients who have consent for examination and treatment on their own will.

Exclusion criteria

Exclusion criteria: (1)Patients with Barrett adenocarcinoma, advanced gastric cancer and obvious other organ cancer. (2)Patients who are pregnant, may be pregnant, or prefer pregnancy during this study. (3)Patients judged unsuitable as subjects by doctor.

Design outcomes

Primary

MeasureTime frame
Positivity rate of AICS in early gastric cancer cases

Secondary

MeasureTime frame
Reduction rate of AICS value at 2 months and 1 year after resection of early gastric cancer in AICS positive cases

Countries

Japan

Contacts

Public ContactHiroaki Kaneko

Yokohama City University Graduate School of Medicine Department of Gastroenterology

hero5722@yokohama-cu.ac.jp045-787-2326

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026